XM tidak memberikan layanan kepada penduduk Amerika Serikat.
S
S

Symrise


Berita

BMW, Legrand, Sodexo

EUROPE RESEARCH ROUNDUP- BMW, Legrand, Sodexo Sept 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BMW, Legrand and Sodexo, on Wednesday. HIGHLIGHTS * BMW BMWG.DE : HSBC cuts target price to EUR 85 from EUR 109 * Kion Group AG KGX.DE : JP Morgan raises to overweight from neutral * Legrand LEGD.PA : JP Morgan raises to overweight from neutral * Phoenix PHNX.L : Peel Hunt cuts target price to 650p from 690p * Sodexo EXHO.PA : JP M
A
A
A
A
B
C
E
E
E
G
I
K
L
L
M
N
P
R
S
S
T
U
V
W
E

Goldman Sachs upgrades Symrise as sales growth trends improve

BUZZ-Goldman Sachs upgrades Symrise as sales growth trends improve ** Goldman Sachs upgrades German flavour and fragrance maker Symrise's SY1G.DE shares to "neutral" from "sell" ** Brokerage cites ongoing strong trends in company's organic sales growth from first half of 2024 and recovery in Symrise's pet food division ** GS expects organic sales g
S
G

Antofagasta, Colonial, and Hill & Smith

EUROPE RESEARCH ROUNDUP-Antofagasta, Colonial, and Hill & Smith Sept 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Antofagasta, Colonial and Hill & Smith, on Friday. HIGHLIGHTS * Antofagasta ANTO.L : Barclays cuts target price to 1,600p from 1,660p * Colonial COL.MC : Jefferies raises to buy from hold * Hill & Smith HILS.L : Berenberg raises target price to 2,500p from 2,350p * Melrose Industries MRON.L : Morgan Stanley initiat
A
B
B
C
C
D
E
F
H
H
I
L
R
S
S
W
A
A
L
M

JPM sees volume/pricing trade-off amid weak demand in focus for European Staples in H2

BUZZ-JPM sees volume/pricing trade-off amid weak demand in focus for European Staples in H2 ** After a mixed H1 for European Staples, focus in H2 will be on the balance of volumes recovery versus easing pricing and accelerated promotion and marketing, as well as demand risks in U.S. and China, J.P. Morgan says ** It flags that the faster-than-expected normalisation in pricing is weighing on revenue growth while consumer demand also shows signs of strains in major markets, U.S.
B
D
H
S
A

Asia Morning Call-Global Markets

UPDATE 1-Asia Morning Call-Global Markets Aug 29 (Reuters) - Stock Markets closing level) Net Chng Stock Markets Net Chng S&P/ASX 200** 8071.4 0.2 NZX 50** 12470.6 19.49 DJIA 41091.42 -159.08 NIKKEI** 38371.76 83.14 Nasdaq 17556.027 -198.793 FTSE** 8343.85 -1.61 S&P 500 5592.21 -33.59 Hang Seng** 17692.45 -182.22 SPI 200 Fut 8008 -18 STI** 3391.03 -7.44 SSEC** 2837.4293 -11.3019 KOSPI** 2689.83 0.58 ---------------------------------------------------------------------------------------- Bonds Bo
A
A
G
N
S
U
J
U
U
U

Asia Morning Call-Global Markets

Asia Morning Call-Global Markets Aug 29 (Reuters) - Stock Markets closing level) Net Chng Stock Markets Net Chng S&P/ASX 200** 8071.4 0.2 NZX 50** 12470.6 19.49 DJIA 40870.54 -379.96 NIKKEI** 38371.76 83.14 Nasdaq 17477.02 -277.8 FTSE** 8343.85 -1.61 S&P 500 5566.96 -58.84 Hang Seng** 17692.45 -182.22 SPI 200 Fut 7983 -43 STI** 3391.03 -7.44 SSEC** 2837.4293 -11.3019 KOSPI** 2689.83 0.58 ---------------------------------------------------------------------------------------- Bonds Bonds JP 10 YR
A
A
G
N
S
U
J
U
U
U

Insurance, chemical stocks keep STOXX 600 at over one-month high

UPDATE 2-Insurance, chemical stocks keep STOXX 600 at over one-month high Ageas jumps after H1 results beat estimates Covestro rises on report ADNOC complete due diligence Chip stocks mixed ahead of Nvidia results French consumer confidence for August in line with estimates STOXX 600 up 0.3% Updated at 1610 GMT By Pranav Kashyap and Lisa Pauline Mattackal Aug 28 (Reuters) - The benchmark European stock index rose to its highest since July on Wednesday, boosted by insurance and chemical stocks ah
A
E
G
L
N
S
A
E
F
G

Symrise slips, analysts points to lack of beat, guidance hike

BUZZ-Symrise slips, analysts points to lack of beat, guidance hike ** Shares in Symrise SY1G.DE slip around 2% after it posted in-line H1 results and confirmed its guidance, with analysts noting that investors were likely expecting more ** "We believe the market was looking rather for a slight beat to the consensus," Konstantin Wiechert at Baader H
G
S
G

Symrise's half-year sales rise on fragrance business growth

UPDATE 2-Symrise's half-year sales rise on fragrance business growth H1 sales rise 6.3% year-on-year to 2.57 billion euros H1 EBITDA rises 11.5% to 529.8 million euros Sees 2024 organic growth at upper end of 5-7% guidance Adds CFO quote in paragraphs 5-6, share reaction in paragraph 8, analyst comments paragraph 9, division detail paragraph 11 By Antonis Pothitos Aug 1 (Reuters) - German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line w
G
K
L
S

Symrise H1 Sales Increase By 6.3%

BRIEF-Symrise H1 Sales Increase By 6.3% Aug 1 (Reuters) - SYMRISE AG SY1G.DE : H1 GROUP SALES INCREASE BY 6.3 % TO EUR 2,565 MILLION; ORGANIC GROWTH OF 11.5 % IN LONG TERM, COMPANY AIMS TO INCREASE ITS SALES TO EUR 7.5 TO 8.0 BILLION BY 2028 IN LONG TERM EBITDA MARGIN SHOULD REMAIN WITHIN A TARGET CORRIDOR OF 20 TO 23 % Source text for Eikon: ID:nE
S

Symrise posts 6% rise in half-year sales, meeting expectations

Symrise posts 6% rise in half-year sales, meeting expectations Aug 1 (Reuters) - German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line with estimates, driven by growth in both of its business areas. Symrise's revenue rose to 2.57 billion euros ($2.78 billion)in the January-June period from 2.41 billion a year earlier.
S

Dsm-firmenich shares jump after core earnings forecast hike

UPDATE 2-Dsm-firmenich shares jump after core earnings forecast hike Adds CEO quote from analyst call in paragraphs 6-8, share move in paragraph 2 By Dimitri Rhodes and Anna Peverieri July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its core earnings forecast for 2024 on Tuesday, banking on savings from the restructuring of its vitamin business and continued integration of DSM and Firmenich's legacy businesses.
G
S
N

Dsm-firmenich raises forecast on vitamin business

Dsm-firmenich raises forecast on vitamin business July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its annual core earnings forecast on Tuesday, helped by the vitamin transformation programme and improving business conditions. The company now sees adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of around 2 billion euros ($2.16 billion) in 2024, up from the 1.9 billion euros previously forecast.
G
S

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead July 26 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 30-Jul-2024 NTS 1COV.DE Covestro AG Half Year 2024 Covestro AG Earnings Release 30-Jul-2024 BMO HEIG.DE Heidelberg Materials AG Half Year 2024 Heidelberg Materials AG Earnings Release 30-Jul-2024 04:30 AIR.PA Airbus SE Half Year 2024 Airbus SE Earnings Release 31-Jul-2024 AMC QGEN.N Qiagen NV Q2 20
A
A
B
F
M
P
S
S
V
V
Q
G

JPM sees a 'more balanced' H1 for European Staples

BUZZ-JPM sees a 'more balanced' H1 for European Staples ** J.P.Morgan expects a "more balanced" H1 for European staples ** Says risk of challenging demand environment and growth threat from weakening pricing and worse forex market are partially offset by better margin outcome and continued volumes improvement ** Adds H1 may also highlight risks in the U.S.
B
D
D
H
J
S
A
P

GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo

BUZZ-GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo ** Goldman Sachs favours consumer ingredient and gasses cos over diversified chemicals and paint makers based on pricing power, as the European chemicals sector faces an uneven recovery ** GS notes Europe's STOXX chemicals sub-index .SX4P is up 13% from its October 2023 tr
A
B
C
C
G
L
S
U
A
A

Bechtle AG, Centrica, Clariant AG

EUROPE RESEARCH ROUNDUP-Bechtle AG, Centrica, Clariant AG July 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bechtle AG, Centrica and Clariant AG, on Monday. HIGHLIGHTS * Akzo Nobel NV AKZO.AS : Goldman Sachs cuts to sell from neutral * Bechtle AG BC8G.DE : Exane BNP Paribas cuts to underperform from neutral * Centrica CNA.L : Berenberg raises to buy from hold * Clariant AG CLN.S : Goldman Sachs raises to buy from neutral * Fin
A
A
A
A
B
B
B
C
C
C
D
D
H
H
P
S
S
A
A
F
J

EU fines IFF for obstructing investigation of suspected fragrance cartel

EU fines IFF for obstructing investigation of suspected fragrance cartel BRUSSELS, June 24 (Reuters) - The European Commission said on Monday it had fined U.S. company International Flavors & Fragrances IFF.N (IFF) and its French affiliate 15.9 million euros ($17.05 million) for obstructing an inspection in an ongoing investigation of a suspected cartel in the supply of fragrances and fragrance ingredients.
G
S
I



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.